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Abstract
Background: Methamphetamine (MA) is a new arrival to the Southeastern United States (US). Incidence of HIV is also
increasing regionally, but data are limited regarding any association between this trend and MA use. We examined
behavioral data from North Carolina (NC) residents newly diagnosed with HIV, collected by the Department of Health
between 2000-2005.
Principal Findings: Among 1,460 newly diagnosed HIV-positive young men, an increasing trend was seen from 2000-2005
in MA use (p=0.01, total n=20). In bivariate analyses, users of MA had significantly greater odds of reporting other
substance use, including alcohol, powder or crack cocaine, marijuana, and methylenedioxymethamphetamine (MDMA,
‘‘ecstasy’’). They were also more likely to have reported sexual activity while traveling outside NC; sex with anonymous
partners; and previous HIV testing. In a predictive model, MA use had a negative association with nonwhite race, and strong
positive associations with powder cocaine, ‘‘ecstasy,’’ or intravenous drug use and being a university student.
Conclusions: Similar to trends seen in more urban parts of the US, MA use among newly diagnosed, HIV-positive young
men is increasing in NC. These data are among the first to demonstrate this relationship in a region with a burgeoning
epidemic of MA use. Opportunities exist for MA-related HIV risk-reduction interventions whenever young men intersect the
healthcare system.
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Introduction
Methamphetamine (MA) use increases risk behaviors for HIV
infection among both heterosexual men[1] and those who have
sex with other men (MSM) [2,3]. As with alcohol and traditional
street drugs such as heroin or cocaine, impaired judgment and
disinhibition of the user may contribute to higher-risk behaviors
[4,5,6]. MA users typically experience up to 12 hours of
heightened alertness, increased energy, and a sense of invulner-
ability, often accompanied by increased libido [7]. Some MSM
who typically are not the receptive partner for anal intercourse
may do so because of drug-induced erectile dysfunction[7] – thus
placing themselves at significantly increased risk for HIV
transmission [8]. Increased pain tolerance, heightened libido,
and a sense of endurance lead to ‘‘marathon’’ sex sessions among
some users, which can last from hours to days [9].
Use of MA is clearly associated with increased HIV incidence
among MSM in major cities of the Pacific coast and Northeastern
United States (US) [10,11], but its impact outside of urban centers
and in other regions of the country is much less clear. In particular,
data on MA in the Southeastern US are scarce. Similar to the rest of
the country, the Drug Enforcement Administration (DEA) acknowl-
edges that clandestine laboratory manufacture of MA in NC
diminished following legal restrictions placed on the availability of
precursor chemicals, like pseudoephedrine. However, the trafficking
of higher-purity MA from Mexico along routes traditionally used for
cocaine hasresultedintheavailabilityofMAinmetropolitancenters
of the state – and increasingly in rural areas [12]. Large portions of
the region are unsampled by major national drug abuse surveillance
networks [13,14], and despite increasing calls for awareness of
MA-associated health risks, the public health response has been
limited.
PLoS ONE | www.plosone.org 1 June 2010 | Volume 5 | Issue 6 | e11314As in most of the Southeast, NC is disproportionately hard-
hit by the HIV epidemic; its case rates exceeded the national
rate in 2006 [15]. Among HIV cases diagnosed in NC, the
proportion among men rose from 66% in 2000 to 73% in
2006; MSM accounted for 25% of cases in 2000 and 36% in
2006 [16,17]. Little is currently known about MA use as a risk
factor for HIV infection among men in NC. The purpose of
this study was to determine the extent of substance use among
NC’s newly diagnosed HIV-positive men from 2000 to 2005,
with special attention to MA. Secondarily, we sought to better




Providers and laboratories in NC use a mandatory, confidential,
name-based system to report all diagnoses of any stage of syphilis
or HIV disease to the state’s Department of Health and Human
Services (NC-DHHS). Each case is assigned to a Disease
Intervention Specialist (DIS), an officer of the NC-DHHS’s
Partner Counseling and Referral Service who arranges for
confidential, voluntary post-diagnosis interviews with each indi-
vidual and collects standardized demographic and behavioral
information. These interviews collect information on demograph-
ics (age, race, and geographic location); college or university
enrollment status; and travel outside of NC, noting when travel
included sexual activity. The DIS documents the subject’s history
of specific HIV risks in the prior year, including both traditional
risk factors (e.g., injection drug use, transactional sex) and non-
traditional ones (e.g., use of Internet for sex-partner seeking,
recreational drug use). The number and gender of sex partners
during a period of HIV infectivity prior to diagnosis are also
recorded. Finally, the DIS reviews communicable disease control
measures and facilitates partner notification and referrals for
treatment or services. With over 90% of all reported HIV cases
interviewed (often multiple times), this database contains the most
comprehensive statewide behavioral data available for new
diagnoses of HIV [18,19].
Description of Investigations Undertaken
We used NC-DHHS records to identify all men aged 18 to 30
who were diagnosed with HIV between 2000 and 2005, as part
of an ongoing investigation[20] of HIV infection in young men
in NC.
Data were abstracted from both the standardized fields and
written narratives of the DIS interview records by trained research
assistants, using a case abstraction form. Data were entered into an
Access database (Microsoft Corporation, Redmond, WA) and de-
identified prior to analysis.
Descriptive analyses provided demographic, clinical, and
behavioral characteristics of the study sample, including reported
drug use. Temporal trends in the data were assessed using two-
sided Cochran-Armitage trend tests. After identifying factors
potentially associated with HIV and drug use from previous
reports in the literature, we conducted bivariate analyses of
characteristics associated with MA use and calculated odds ratios
(OR) with 95% confidence intervals (CI). Finally, we developed an
exploratory multivariate logistic regression model to help define
those factors most associated with MA use in the cohort. We used
likelihood ratio testing to eliminate non-significant predictor
variables from an initial model inclusive of all factors of interest.
(Factors of interest were not limited solely to those variables with
statistical significance in bivariate comparisons.) Reported p-values
are all two-sided, with a=0.05. All analyses were completed using
Stata/IC v 10.1 (Stata Corporation, College Station, TX).
Ethics
Because of its state-sanctioned role in epidemiological surveil-
lance, our study was exempted from Institutional Review Board
(IRB) approval.
Results
Between 2000 and 2005, a total of 7,011 men with a new
diagnosis of HIV were reported in NC, of whom 20.8% were
between the ages of 18 to 30 (n=1,460). Numbers of reported
HIV cases among these young men increased each year over the
period, rising from 178 in 2000 to 323 in 2005. The median age
was 25. Non-whites made up 69.2% of the sample (n=1,011; 971
black, 40 other); 10.7% were Hispanic. Of these men, 51.3%
reported sex only with other men, while 14.9% reported sex with
both men and women in year before their infection.
Over the five-year period, a statistically significant trend of
increasing MA use was reported, rising from 0.6% of men
diagnosed with HIV in 2000 to 3.1% in 2005 (p=0.01, total
n=20). In the same period, powder cocaine (p=0.193) and
marijuana (p=0.019) use increased slightly while crack cocaine
use fell (p=0.083). Injection drug use was infrequent and did not
change over time (p=0.689).
In bivariate analyses (Table 1), MA users were significantly less
likely to be black (OR 0.22, 95% CI 0.08, 0.60), and tended to
have sex with men only (OR 1.81, 95% CI 0.60, 5.48). Men who
used MA had significantly greater odds of reporting polysubstance
use than non-MA users. The strongest associations were noted for
use of powder cocaine (OR 21.0, 95% CI 8.21, 53.7), intravenous
drugs (OR 21.5, 95% CI 7.18, 64.3), and methylenedioxy-
methamphetamine (MDMA, ‘‘ecstasy’’, OR 20.1, 95% CI 7.25,
56.0). We also noted significantly greater odds of alcohol, crack
cocaine, and marijuana consumption among MA users.
Compared with non-users, men who reported MA use had
greater odds of reporting sex with anonymous partners and having
met sex partners in bars or clubs. The number of reported sex
partners did not differ significantly between MA users and non-
users, nor were users any more likely to have sex in exchange for
drugs or money, or sex with a partner known by them to be HIV-
positive. (Data not shown). MA users were more likely to have had
sex while traveling outside of NC (OR 3.18, 95% CI 1.29, 7.82).
Coinfection with early syphilis (primary or secondary) at the time
of HIV diagnosis was more likely among MA users (OR 3.94, 95%
CI 1.29, 12.0), and users had greater odds of reporting prior
testing for HIV (OR 4.10, 95% CI 1.48, 11.4) than those who did
not use MA.
In an exploratory multivariable predictive model (Table 2), MA
use was most strongly associated with use of powder cocaine,
MDMA, or intravenous drugs, and being a student in a college
or university. Nonwhite race was negatively associated with MA
use.
Discussion
Our study is the first statewide description of MA use among
newly diagnosed HIV-positive young men in the Southeastern US,
and demonstrates an increasing trend in MA use among young
men diagnosed with HIV in NC from 2000 to 2005. Although
these cross-sectional surveillance data cannot demonstrate causa-
tion, certain findings have implications for public health policy in
NC and other states in the region.
MA and HIV in North Carolina
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samples from major cities in previous years. They were often self-
identified as MSM[21,22] and tended to engage in more HIV-
associated risk behaviors than their non-using counterparts
[23,24,25,26]. They frequented clubs or bars[21] and had
anonymous sex partners[27] – often met in a bar, club, or
Table 1. Bivariate analyses of factors associated with methamphetamine use among 1,460 men aged 18–30 diagnosed with HIV in
North Carolina, 2000 to 2005.
Unadjusted odds of reporting
methamphetamine use
n No. (%) MA users OR (95% CI) P
Age
18–24 671 9 (1.3) 0.96 (0.40, 2.33) 0.931
25–30 789 11 (1.4) Ref
Race
Black 971 6 (0.6) 0.22 (0.08, 0.60) 0.003
Other 40 2 (5.0) 1.90 (0.41, 8.82) 0.411
White 446 12 (2.7) Ref
Gender of sex partner(s)
Men and women 218 1 (0.5) 0.41 (0.05, 3.67) 0.424
Men only 750 15 (2.0) 1.81 (0.60, 5.48) 0.297
Women only 358 4 (1.1) Ref
Alcohol use 790 17 (2.2) 4.89 (1.43, 16.8) 0.012
Powder cocaine use 130 13 (10) 21.0 (8.21, 53.7) ,0.001
Crack cocaine use 87 6 (6.9) 7.19 (2.69, 19.2) ,0.001
Marijuana use 465 11 (2.4) 2.65 (1.09, 6.45) 0.031
MDMA* use 36 6 (17) 20.1 (7.25, 56.0) ,0.001
Intravenous drug use 27 5 (19) 21.5 (7.18, 64.3) ,0.001
Patron of clubs or bars 437 10 (2.3) 2.37 (0.98, 5.74) 0.055
Anonymous sex partners 438 12 (2.7) 3.57 (1.45, 8.80) 0.006
Sex in bars or clubs 54 2 (3.7) 2.97 (0.67, 13.1) 0.152
Met sex partners in bars 290 8 (2.8) 2.74 (1.11, 6.76) 0.029
Met sex partners online 219 6 (2.7) 2.47 (0.94, 6.50) 0.067
Travel outside NC that included sexual activity 474 12 (2.5) 3.18 (1.29, 7.82) 0.012
Student in college or university 191 5 (2.6) 2.25 (0.81, 6.26) 0.121
Coinfected with early syphilis 90 4 (4.4) 3.94 (1.29, 12.0) 0.016
HIV testing history
Documented 356 10 (2.8) 4.10 (1.48, 11.4) 0.007
No previous 857 6 (0.7) Ref
*MDMA, methylenedioxymethamphetamine.
doi:10.1371/journal.pone.0011314.t001
Table 2. Multivariate analyses of factors associated with methamphetamine use among 1,460 men aged 18–30 diagnosed with
HIV in North Carolina, 2000 to 2005.
Adjusted odds of reporting methamphetamine use
n OR (95% CI) P
Nonwhite race 1011 0.37 (0.14, 1.01) 0.053
Powder cocaine use 130 12.6 (4.33, 36.6) ,0.001
MDMA* use 36 6.00 (1.90, 19.0) 0.002
Intravenous drug use 27 8.01 (2.23, 28.75) 0.001
Student in college or university 191 5.31 (1.63, 17.4) 0.006
*MDMA, methylenedioxymethamphetamine.
doi:10.1371/journal.pone.0011314.t002
MA and HIV in North Carolina
PLoS ONE | www.plosone.org 3 June 2010 | Volume 5 | Issue 6 | e11314online. Internet sex-seeking was prominent among both users and
non-users.
In particular, two findings were noteworthy: coinfection with
early syphilis and the HIV testing behavior of MA users. NC is
currently experiencing a major syphilis outbreak, and MSM are
disproportionately impacted [28]. Studies from urban settings
demonstrate MA use as a risk factor for incident syphilis
infection[29,30], and previous work in NC suggests increased
sexual risk-taking behavior among stimulant users [31].
Frequent HIV testers may regard this as a method of primary
prevention; while acknowledging their high-risk sexual activities,
they may use a recent negative HIV test as evidence of their
‘‘safety’’ as a partner for unprotected intercourse [32]. Currently,
counselors at HIV testing centers (including sexually transmitted
infection (STI) clinics) in NC record very limited information
about sexual and injection drug HIV risk behaviors on surveillance
forms. Our findings underscore the need to expand the inquiry
and to more broadly discuss and record non-injection drug use,
the circumstances and environment in which drugs are used, and
whether or not sexual activity occurs while intoxicated. More
comprehensive drug-use assessments at STI clinics could greatly
improve our understanding of the expansion of new drugs like MA
in the absence of a robust regional surveillance system for drug
use.
While relatively few men in this cohort acknowledged MA use
in the period prior to their HIV diagnosis, the proportion who did
increased significantly over the five-year study period – the same
period over which MA infiltration into NC began in earnest. US
DEA annual ‘‘busts’’ of clandestine MA laboratories in NC grew
from 14 in 2000 to 322 in 2005, but these numbers do not account
for higher-purity ‘‘crystal’’ MA imported via established cocaine
trafficking routes from Mexico [12]. Thus, these users with newly
diagnosed HIV infection may be sentinels for what we will see in
the future, as MA use expands in our state.
The inverse association of black race with MA use is noteworthy
in our study, and echoes qualitative data collected elsewhere in the
Southeastern US. Community and cultural norms among black
drug users favor the use of crack or powder cocaine and fuel a
strong suspicion of MA as being an impure and unpredictable
drug [33]. This trend should not provide a false sense of security,
however; although our total number of MA users was small, a
third of them were black.
Travel that included sexual activity was associated with MA use
in our analyses. Since almost 75% of our sample self-identified as
either MSM or having sex with both men and women, many of
these young men may intentionally explore their sexual identities
away from the close-knit, small communities in which they live.
Studies of MSM in San Francisco demonstrated increased HIV-
associated risk behavior when traveling away from home for
weekend-long dance (‘‘circuit’’) parties [34]. In the case of MA,
drug availability may also be an issue; the small numbers of users
identified in our sample suggests that the drug had yet to widely
disseminate among young men in NC by 2005.
Our results have several limitations. Only a small percentage of
the entire cohort were MA users. Data are self-reported by
individuals being interviewed by an officer of the NC-DHHS, and
thus social desirability bias has likely resulted in underestimation of
the prevalence of both drug use and sexual risk behavior. Data
collection bias may have improved the capture of information on
MA use toward the end of the period, as awareness of expanded
availability and use of the drug diffused through to more DIS
officers. Additionally, ascertainment bias may have been intro-
duced through the use of chart abstraction, although those
reviewing the charts were trained for the task. Finally, our data
pertain only to men aged 18 to 30, so we cannot characterize MA
use or associated factors in men over age 30 in NC.
In summary, the use of MA among young men newly diagnosed
with HIV underscores the fact that MA use exists in the Southeast
US, and may be expanding among groups at high risk for HIV
acquisition and transmission. HIV risk-reduction messages for MA
users should be directed at young, college-aged men, including
MSM – with special attention to any point of intersection with the
healthcare system that includes STI or HIV testing.
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